Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

Share Price is delayed by 15 minutes
Get Live Data
2,493.00    74.00 (3.06%)
Bid:
2,491.00
Ask:
2,492.00
Spread: 1.00 (0.04%)
Market Cap: £7.41b
SMIN Live PriceLast checked at - London Stock Exchange

Intraday Smiths Group Share Chart

Smiths Group 3rd Quarter Results

21 May 2024 07:00

RNS Number : 1640P
Smiths Group PLC
21 May 2024
 

News Release

21 May 2024

 

 

SMITHS GROUP PLC - Q3 TRADING UPDATE

Pioneers of progress - improving our world through smarter engineering

 

Strong organic revenue growth; FY2024 guidance reaffirmed

Smiths Group plc ("Smiths" or "the Group") today announces its trading statement for the third quarter, and nine months, to 3 May 2024.

Third quarter organic revenue growth1 advanced to +7.7% bringing organic revenue growth for the nine months to 3 May 2024 to +5.2%. This strong growth was delivered against a record nine-month FY2023 comparator of +13.4%. The third quarter period this year benefited from four extra trading days and adjusting for this, the organic revenue growth on a comparable basis was +6.1% (YTD 4.6%).

 

As a result of the Group's performance progression and a strong order book, we are again reaffirming our FY2024 guidance of full-year organic revenue growth of 4-6%, with continued margin expansion.

 

The third quarter performance reflected strong demand in John Crane, Smiths Detection and Flex-Tek aerospace and the gradually improving market conditions in Flex-Tek construction and Smiths Interconnect.

 

· John Crane continues to see strong demand and delivered high single digit organic revenue growth in the quarter.

· Smiths Detection continues to deliver against its order book with low double-digit organic growth in the quarter, and ongoing high levels of installation activity.

· Flex-Tek saw continued strength in aerospace and is seeing a gradual recovery in US construction, resulting in marginal organic growth in the quarter.

· Smiths Interconnect also delivered marginal organic growth in the quarter.

 

Roland Carter, Chief Executive Officer, commented:

"In my first quarter as CEO, I am pleased to report that organic revenue growth stepped up, as we expected. We continued to deliver strong results, building further on last year's record performance and our solid first half. Our strategy of accelerating growth, improving execution and investing in our people is driving performance. I would like to thank all my colleagues across the Group for their commitment and contribution.

 

"Our strong results for the year to date, together with our visibility for the final quarter, gives us confidence in our full-year guidance of organic revenue growth in our medium-term target range of 4-6%, with continued margin expansion."

 

 

FY2024 results

Smiths will publish its results for the year ending 31 July 2024 on Tuesday, 24 September 2024.

 

1 Organic revenue growth excludes the effects of foreign exchange and M&A.

 

Investor enquiries

Media enquiries

 

Siobhán Andrews, Smiths Group+44 (0)7920 230093siobhan.andrews@smiths.com

 

Tom Steiner, Smiths Group

+44 (0)7787 415891

tom.steiner@smiths.com

 

Ana Pita da Veiga

+44 (0)7386 689442

 ana.pitadaveiga@smiths.com

Alex Le May, FTI Consulting+44 (0)7702 443312smiths@fticonsulting.com

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

 

About Smiths Group

For over 170 years, Smiths Group has been pioneering progress by improving our world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient, andbetter-connected world, across four major global markets: Energy, General Industry, Safety & Security and Aerospace. Listed on the London Stock Exchange, Smiths employs more than 15,000 colleagues in over50 countries. For more information visit www.smiths.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTPPUPAAUPCGAU
Date   Source Headline
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme
26th Mar 20247:01 amRNSSmiths Group half year results
26th Mar 20247:00 amRNSDirectorate Change
1st Mar 20247:00 amRNSSmiths sells 830,000 shares in ICU Medical Inc
29th Feb 20249:00 amRNSDirectors' Change in Responsibilities
1st Feb 202410:15 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirectors' Change in Responsibilities
30th Nov 20237:00 amRNSSmiths Group plc - John Crane deep dive
16th Nov 20231:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSSmiths Group plc - Q1 Trading Update
2nd Nov 20232:45 pmRNSDirector/PDMR Shareholding
1st Nov 202310:00 amRNSBlock listing Interim Review
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:25 pmRNSDirector/PDMR Shareholding
12th Oct 202312:35 pmRNSAnnual Financial Report and AGM 2023
4th Oct 202310:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:10 pmRNSTotal Voting Rights
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSSmiths Group FY23 Full Year Results
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.